These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34561707)

  • 1. Clinical significance of part-solid lung cancer in the eighth edition TNM staging system.
    Okamoto T; Miyawaki M; Toyokawa G; Karashima T; Abe M; Takumi Y; Hashimoto T; Osoegawa A; Tagawa T; Takeuchi H; Shimokawa M; Sugio K
    Interact Cardiovasc Thorac Surg; 2022 Jan; 34(2):219-226. PubMed ID: 34561707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the radiological definition of part-solid tumour in lung cancer?†.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):242-247. PubMed ID: 28119328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
    Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
    Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
    Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer.
    Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
    Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35293580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer.
    Sakurai H; Goto Y; Yoh K; Takamochi K; Shukuya T; Hishida T; Tsuboi M; Yoshida K; Ohde Y; Okumura S; Taguri M; Kunitoh H
    Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38598462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Part-Solid and Pure-Solid Tumors in the TNM Classification of Lung Cancer (Eighth Edition).
    Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T
    Thorac Cardiovasc Surg; 2019 Jun; 67(4):306-314. PubMed ID: 29843187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic ability of new T1 descriptors in the tumour, node and metastasis classification of surgically treated non-small-cell lung cancer.
    Takenaka T; Yamazaki K; Miura N; Takeo S
    Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):714-719. PubMed ID: 29788086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of solid-part tumour volume doubling time in patients with radiological part-solid or solid lung cancer.
    Setojima Y; Shimada Y; Tanaka T; Shigefuku S; Makino Y; Maehara S; Hagiwara M; Masuno R; Yamada T; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2020 Apr; 57(4):763-770. PubMed ID: 31746987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer.
    Inoue M; Minami M; Sawabata N; Utsumi T; Kadota Y; Shigemura N; Okumura M
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1445-9. PubMed ID: 20137967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of visceral pleural invasion in pure-solid and part-solid lung cancer patients.
    Okada S; Hattori A; Matsunaga T; Takamochi K; Oh S; Inoue M; Suzuki K
    Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):303-310. PubMed ID: 32918675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of solid portions in non-small cell lung cancer-the solid part is not always measurable for clinical T factor.
    Fukui M; Takamochi K; Ouchi T; Koike Y; Yaguchi T; Matsunaga T; Hattori A; Suzuki K; Hoshina A; Yamashiro Y; Oh S; Suzuki K
    Jpn J Clin Oncol; 2021 Jan; 51(1):114-119. PubMed ID: 33094807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer.
    Chen K; Chen H; Yang F; Sui X; Li X; Wang J
    Clin Lung Cancer; 2017 Nov; 18(6):e457-e466. PubMed ID: 28539214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Pathological Staging Validation in the Eighth Edition of the TNM Classification for Lung Cancer: Correlation between Solid Size on Thin-Section Computed Tomography and Invasive Size in Pathological Findings in the New T Classification.
    Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Hishida T; Tsuboi M
    J Thorac Oncol; 2017 Sep; 12(9):1403-1412. PubMed ID: 28627462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma.
    Song SH; Ahn JH; Lee HY; Lee G; Choi JY; Kang J; Kim EY; Han J; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Shim YM
    Eur Radiol; 2016 Jun; 26(6):1538-46. PubMed ID: 26455720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Aokage K; Saji H; Watanabe SI;
    J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1469-1480. PubMed ID: 32451073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of preoperative biopsy in radiological solid-dominant clinical stage I non-small-cell lung cancer.
    Huang CS; Chien HC; Chen CK; Yeh YC; Hsu PK; Chen HS; Hsieh CC; Hsu HS; Huang BS; Shih CC
    Interact Cardiovasc Thorac Surg; 2021 Apr; 32(4):537-545. PubMed ID: 33332546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of Early-stage Part-solid and Pure-solid Lung Adenocarcinomas.
    Kinoshita F; Toyokawa G; Matsubara T; Kozuma Y; Haratake N; Takamori S; Akamine T; Hirai F; Takenaka T; Tagawa T; Maehara Y
    Anticancer Res; 2019 May; 39(5):2665-2670. PubMed ID: 31092466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.